Aeon Biopharma earnings were -$54.6M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest AEON earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.2M, down 90.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AEON reported annual earnings of -$39.2M, with -193.4% growth. The next AEON earnings date is Nov 13, 2026.
On AEON's earnings call on Aug 11, 2026, Aeon Biopharma (NYSEMKT: AEON) reported Q2 2026 earnings per share (EPS) of -$0.02, up 96.67% year over year. Total AEON earnings for the quarter were -$1.16 million. In the same quarter last year, Aeon Biopharma's earnings per share (EPS) was -$0.60.
The next AEON earnings date is Nov 13, 2026. Add AEON to your watchlist to be reminded of Aeon Biopharma's next earnings date.
Is Aeon Biopharma profitable or losing money?
As of the last Aeon Biopharma earnings report, Aeon Biopharma is currently losing money. Aeon Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$54.62 million, a 3,238.81% increase year over year.
What was AEON's earnings growth in the past year?
As of Aeon Biopharma's earnings date in Aug 11, 2026, Aeon Biopharma's earnings has grown year over year. AEON earnings in the past year totalled -$54.62 million.
What are Aeon Biopharma's earnings expectations?
The current EPS estimate for Aeon Biopharma's earnings report in Nov 13, 2026 is -$0.07.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.